83.5%
β-GUS inhibitorscolorectal cancer (CRC)irinotecan therapychemical intervention
…duction is prevailingly thought to mediate intestinal toxicity, β-GUS inhibitors confer limited benefits in the clinic.Objective This study aime…
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: β-GUS inhibitors ×
β-GUS inhibitors
This drug is selected. Its supporting articles are shown below.